Early Access — free while we kick the tires
EdgarHawk

5AM Partners VII, LLC

10% Owner

10% Owner
1 filing analyzed · 1 company · Latest 2024-09-13

Companies

Company Buys Sells Direction
Skye Bioscience, Inc. SKYE 0 6 Net selling

Activity

September 2024
2024-09-13 Skye Bioscience, Inc. SKYE
high
Sell
266,337 shares
$1,750,352
Significance 7/10

5AM Partners VII, LLC sold 266,337 shares (80.1% of stake) at $6.57 average, reducing holdings to 66,277 shares

5AM Partners VII, LLC executed 6 separate sales totaling 266,337 shares for $1,750,352.22 on 2024-09-11 and 2024-09-13, at a blended average price of $6.57. The filing represents a major position reduction: the insider sold 80.1% of its pre-transaction holdings, retaining only 66,277 shares. The timing is notable given the insider's same-ticker history—both prior buys at SKYE showed positive 90-day returns (29.1% and 624.2%), establishing a pattern of well-timed entries; however, the current sell occurs as the stock is -66.7% from its 52-week high and -42.8% over 90 days. The underlying company remains unprofitable with net income of $-7,902,816.00. The scale and decisiveness of this exit—reducing the stake by four-fifths—distinguishes it from incremental reductions and warrants monitoring to determine whether this reflects changed conviction or portfolio reallocation.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access